Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Abeona Therapeutics Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +5 vs. Q2 2025
- Shares held
- 35.6M
- +684.6K (+2.0%) vs. Q2 2025
- Total value
- $187.9M
- −$10.3M (−5.2%) vs. Q2 2025
- New holders
- 19
- 38 more added
- Sold out
- 14
- 24 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $243.3M |
| Q1 2026 | 108 | $177.1M |
| Q4 2025 | 104 | $205.2M |
| Q3 2025 | 100 | $187.9M |
| Q2 2025 | 95 | $198.2M |
| Q1 2025 | 71 | $141.2M |
| Q4 2024 | 65 | $170.4M |
| Q3 2024 | 55 | $181.7M |
| Q2 2024 | 48 | $127.8M |
| Q1 2024 | 56 | $104.7M |
| Q4 2023 | 48 | $70.8M |
| Q3 2023 | 40 | $52.5M |
| Q2 2023 | 37 | $37.9M |
| Q1 2023 | 33 | $21.2M |
| Q4 2022 | 41 | $28.5M |
| Q3 2022 | 25 | $3.62M |
| Q2 2022 | 44 | $4.51M |
| Q1 2022 | 56 | $10.3M |
| Q4 2021 | 53 | $13.7M |
| Q3 2021 | 60 | $28.3M |
| Q2 2021 | 73 | $43.4M |
| Q1 2021 | 78 | $58.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Abeona Therapeutics Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Activest Wealth Management | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −275,915−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −111,277−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −102,336−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −68,614−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −55,122−100.0% | Sold out |
| Bollard Group LLC | 0 | $0 | 0.00% | −49,393−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −22,416−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −21,765−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,274−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −11,794−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −2,393−100.0% | Sold out |
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −2,350−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −243−100.0% | Sold out |